BME : ALM.MC
$0.14 (1.27%)
BME
Carlos Gallardo Piqué
Drug Manufacturers - Specialty & Generic
Healthcare
ALM.MC
2108
ES
EUR
0.19
2.32
1.73
1.03
0.37
$1.11B
1.73
1.62
12.65
0.89
$0.22
$46.2M
5.08%
5.28%
4.84%
3.08%
33.81
0.15
0.15
3/5
1 Analysts
%
3.24
6/9
$397.1M
$2.33B
$822.6M
$458M
No key metrics data available.
| Name | Title |
|---|---|
| Pablo Divasson del Fraile | Senior Director of Investor Relations |
| Paul Rittman | Member of Management Board and President & GM of Almirall US |
| Lidia Martin Pereda | Chief Commercial Officer of Europe & International and Member of Management Board |
| Karl Ziegelbauer | Chief Scientific Officer & Member of Management Board |
| Volker Koscielny | Chief Medical Officer & Member of Management Board |
| Esteve Conesa Panicot | Chief People & Culture Officer and Member of Management Board |
| Jon U. Garay Alonso | Chief Financial Officer & Member of Management Board |
| Isabel Gomes | Company Vice Secretary,Chief Legal Officer, General Counsel & Member of Management Board |
| Carlos Gallardo Piqué | CEO, Member of Management Board & Chairman of the Board |
| Eloi Crespo Cervera | Chief Industrial Operations Officer & Member of Management Board |
No votes yet today — be the first to share your view!
About Almirall, S.A. (BME:ALM.MC) Stock
Almirall, S.A. is a biopharmaceutical firm dedicated to the discovery, development, production, and commercialization of treatments primarily focused on skin health. Operating globally, with a significant presence in Europe and the United States, its product line targets various dermatological ailments such as actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, and acne, alongside rare skin conditions. Beyond its core dermatology focus, the company also offers solutions for cardiovascular, musculoskeletal, respiratory, and nervous system disorders, as well as products for digestive health, anti-infectives for systemic use, genitourinary conditions and sex hormones, immunostimulants, and systemic hormonal preparations. Its extensive portfoli ... o includes a range of well-known medications, such as Ilumetri, Solaraze, Skilarence, and Klisyri, among others. Almirall fosters strategic partnerships with numerous entities to advance its pipeline, including research institutions like the University of Dundee and commercial partners such as Eli Lilly and Company. Founded in Barcelona, Spain, in 1943, the company adopted its current name, Almirall, S.A., in May 2009, having previously been known as Laboratorios Almirall, S.A.
Frequently Asked Questions
What is the current Almirall, S.A. (ALM.MC) stock price?
Almirall, S.A.(BME:ALM.MC) stock price is $11.2 in the last trading session. During the trading session, ALM.MC stock reached the peak price of $13.98 while $10.06 was the lowest point it dropped to. The percentage change in ALM.MC stock occurred in the recent session was 1.27% while the dollar amount for the price change in ALM.MC stock was $0.14.
ALM.MC's industry and sector of operation?
The BME listed ALM.MC is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of ALM.MC?
Pablo Divasson del Fraile
| Senior Director of Investor Relations
Paul Rittman
| Member of Management Board and President & GM of Almirall US
Lidia Martin Pereda
| Chief Commercial Officer of Europe & International and Member of Management Board
Karl Ziegelbauer
| Chief Scientific Officer & Member of Management Board
Volker Koscielny
| Chief Medical Officer & Member of Management Board
How many employees does ALM.MC have?
Number of ALM.MC employees currently stands at 2108. ALM.MC operates from Ronda Del General Miter, 151, Barcelona, CT 08022, ES.
Link for ALM.MC official website?
Official Website of ALM.MC is: https://www.almirall.com
How do I contact ALM.MC?
ALM.MC could be contacted at phone #34 93 291 30 00 and can also be accessed through its website. ALM.MC operates from Ronda Del General Miter, 151, Barcelona, CT 08022, ES.
How many shares of ALM.MC are traded daily?
The average number of ALM.MC shares traded daily for last 3 months was 119.44K.
What is the market cap of ALM.MC currently?
The market value of ALM.MC currently stands at $2.44B with its latest stock price at $11.2